Dishman Carbogen Amcis Ltd.

245.60 +6.95 ▲2.9%

23 February 2024, 04:01:00 PM
Volume: 363,045

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.dishmangroup.com
Market Cap 3,850.59 Cr.
Enterprise Value(EV) 5,404.19 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -9.84 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.88 Trailing Twelve Months Ending 2023-12
Book Value / Share 364.27 Trailing Twelve Months Ending 2023-12
Price to Book Value 0.67 Calculated using Price: 245.60
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 15.68 Cr. 156,783,095 Shares
FaceValue 2
About Dishman Carbogen Amcis Ltd.
The company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.

Dishman Carbogen Amcis Ltd. Delivery

Delivered Qty
Traded Qty

Dishman Carbogen Amcis Ltd. Performance

1 Day
+2.91%
1 Week
+19.83%
1 Month
+26.14%
3 Month
+41.43%
6 Month
+56.13%
1 Year
+112.92%
2 Year
+45.76%
5 Year
+30.60%
10 Year

Dishman Carbogen Amcis Ltd. Fundamental Ratios

7 years 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 3654.02 6.05 4.01 2.86 -2.89 0.32 -0.52
Return on Capital Employed (%) 4.6 4.67 5.79 3.93 -0.26 0.76 0.43
Return on Assets (%) 2.21 2.25 2.9 2.04 -2 0.21 -0.33

Dishman Carbogen Amcis Ltd. Balance Sheet

Particulars 8 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 4,814 5,107 5,379 5,715 5,699 5,549 5,810 5,771
Non Curr. Liab. 767 884 743 909 1,367 1,665 1,831 1,840
Curr. Liab. 994 1,178 1,198 1,569 1,290 1,420 1,798 1,882
Minority Int.
Equity & Liab. 6,574 7,169 7,321 8,193 8,356 8,634 9,439 9,493
Non Curr. Assets 5,241 5,623 5,767 6,414 6,652 6,795 7,521 7,530
Curr. Assets 1,333 1,546 1,554 1,779 1,704 1,839 1,918 1,963
Misc. Exp. not W/O
Total Assets 6,574 7,169 7,321 8,193 8,356 8,634 9,439 9,493

Dishman Carbogen Amcis Ltd. Profit and Loss

Particulars 8 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1,714 1,695 2,059 2,044 1,912 2,141 2,413 2,580
Other Income 26 53 54 44 39 49 28 28
Total Income 1,740 1,748 2,112 2,088 1,951 2,190 2,441 2,607
Total Expenditure -1,260 -1,257 -1,507 -1,546 -1,638 -1,815 -2,081 -2,304
PBIDT 479 491 606 542 313 375 360 303
Interest -49 -49 -57 -62 -48 -57 -86 -113
Depreciation -214 -211 -240 -283 -308 -308 -281 -302
Taxation -71 -76 -98 -39 -100 22 25 6
Exceptional Items -22 -15 -48 -49
PAT 145 155 210 159 -165 18 -30 -154
Minority Interest
Share Associate
Other Related Items 15
Consolidated Net Profit 161 155 210 159 -165 18 -30 -154
Adjusted EPS 10 13 10 -11 1 -2 -10

Dishman Carbogen Amcis Ltd. Cash Flow

Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 303 226 282 585 513 355 220
Cash Fr. Inv. -142 -297 -169 -442 -380 -619 -448
Cash Fr. Finan. -137 78 -102 -98 -11 130 250
Net Change 23 7 11 46 122 -133 22
Cash & Cash Eqvt 59 66 76 122 244 110 132

Dishman Carbogen Amcis Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 59.32 59.32 59.32 59.32 59.32 59.32 59.32 59.32 59.32
Public 40.68 40.68 40.68 40.68 40.68 40.68 40.68 40.68 40.68
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Dishman Carbogen Amcis Ltd. Announcements

Thu, 22 Feb 2024
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pls. find enclosed herewith transcript of earning conference call arranged on 15.02.2024.
Thu, 15 Feb 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
AUDIO RECORDING OF EARNINGS CONFERENCE CALL ARRANGED ON 15TH FEBRUARY 2024
Wed, 14 Feb 2024
Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS' LIMITED REVIEW REPORT FOR THE THIRD QUARTER ENDED 31/12/2023
UN-AUDITED FINANCIAL RESULTS AND STATUTORY AUDITORS LIMITED REVIEW REPORT FOR THE THIRD QUARTER ENDED 31/12/2023

Dishman Carbogen Amcis Ltd. Technical Scans

Fri, 23 Feb 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing 52 Week High Close Crossing 52 Week High
Closing Above Previous High Closing Above Previous High

Dishman Carbogen Amcis Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,560.95 +0.2%
Cipla Ltd. 118,375.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,742.15 -0.4%
Divi's Laboratories Ltd. 96,748.70 3,636.05 -0.3%
Zydus Lifesciences Ltd. 93,335.34 922.10 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,627.10 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 31.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,627.10 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 4.57 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,627.10 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,627.10 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,627.10 +0.7%

Dishman Carbogen Amcis Ltd. FAQ's

What is Dishman Carbogen Amc share price?

Can I buy Dishman Carbogen Amc shares now?

What is the Market Cap of Dishman Carbogen Amc?

What are the key metrics to analyse Dishman Carbogen Amc?

What is the 52 Week High and Low of Dishman Carbogen Amc?

What is the trend of Dishman Carbogen Amc share price?